Zalutsky MR - Search Results

1

Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.

Zhou Z, Zalutsky MR, Chitneni SK. Zhou Z, et al. Among authors: zalutsky mr. Mol Pharm. 2021 Oct 4;18(10):3871-3881. doi: 10.1021/acs.molpharmaceut.1c00531. Epub 2021 Sep 15. Mol Pharm. 2021. PMID: 34523337 Free PMC article.

2

Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.

Vaidyanathan G, Bigner DD, Zalutsky MR. Vaidyanathan G, et al. Among authors: zalutsky mr. J Nucl Med. 1992 Aug;33(8):1535-41. J Nucl Med. 1992. PMID: 1634947 Free article.

3

Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Among authors: zalutsky mr. Nucl Med Biol. 1995 Aug;22(6):759-64. doi: 10.1016/0969-8051(95)00028-v. Nucl Med Biol. 1995. PMID: 8535336

4

Molecular imaging of hypoxia.

Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. Among authors: zalutsky mr. J Nucl Med. 2011 Feb;52(2):165-8. doi: 10.2967/jnumed.110.075663. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233176 Free PMC article. Review.

5

A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5).

Chitneni SK, Bida GT, Dewhirst MW, Zalutsky MR. Chitneni SK, et al. Among authors: zalutsky mr. Nucl Med Biol. 2012 Oct;39(7):1012-8. doi: 10.1016/j.nucmedbio.2012.05.006. Epub 2012 Jun 22. Nucl Med Biol. 2012. PMID: 22727821 Free PMC article.

6

18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.

Chitneni SK, Bida GT, Yuan H, Palmer GM, Hay MP, Melcher T, Wilson WR, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. Among authors: zalutsky mr. J Nucl Med. 2013 Aug;54(8):1339-46. doi: 10.2967/jnumed.112.116293. Epub 2013 Jun 5. J Nucl Med. 2013. PMID: 23740105 Free PMC article.

7

Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.

Chitneni SK, Bida GT, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. Among authors: zalutsky mr. J Nucl Med. 2014 Jul;55(7):1192-7. doi: 10.2967/jnumed.114.137448. Epub 2014 May 22. J Nucl Med. 2014. PMID: 24854792 Free PMC article.

8

D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination.

Pruszynski M, Koumarianou E, Vaidyanathan G, Chitneni S, Zalutsky MR. Pruszynski M, et al. Among authors: zalutsky mr. Nucl Med Biol. 2015 Jan;42(1):19-27. doi: 10.1016/j.nucmedbio.2014.08.007. Epub 2014 Aug 13. Nucl Med Biol. 2015. PMID: 25240914 Free PMC article.

9

Copper signaling axis as a target for prostate cancer therapeutics.

Safi R, Nelson ER, Chitneni SK, Franz KJ, George DJ, Zalutsky MR, McDonnell DP. Safi R, et al. Among authors: zalutsky mr. Cancer Res. 2014 Oct 15;74(20):5819-31. doi: 10.1158/0008-5472.CAN-13-3527. Cancer Res. 2014. PMID: 25320179 Free PMC article.

10

Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.

Chitneni SK, Bida GT, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. Among authors: zalutsky mr. J Nucl Med. 2015 Apr;56(4):653-4. doi: 10.2967/jnumed.115.154054. Epub 2015 Mar 5. J Nucl Med. 2015. PMID: 25745087 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page